Ignite Creation Date:
2024-05-06 @ 3:30 PM
Last Modification Date:
2024-10-26 @ 1:51 PM
Study NCT ID:
NCT04658758
Status:
UNKNOWN
Last Update Posted:
2020-12-14
First Post:
2020-11-30
Brief Title:
The Incidence and Risk of Vein Infusion Phlebitis After Intravenous Infusion of Proton Pump Inhibitors
Sponsor:
Assistance Publique - Hôpitaux de Paris
Organization:
Assistance Publique - Hôpitaux de Paris
Study Overview
Official Title:
Risk Assessment and Incidence of Vein Infusion Phlebitis After Intravenous Infusion of Proton Pump Inhibitors
Status:
UNKNOWN
Status Verified Date:
2020-12
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
VeinIPP
Brief Summary:
Intermittent or continuous proton pump inhibitor PPI therapy are recommended for high-risk bleeding ulcers according to the French Society of Gastroenterology The prevalence of incidence of vein infusion phlebitis after PPI intravenous infusion is high in geriatric acute ward about 10 of severe vein infusion phlebitis
The primary of objective of the study is to determinate the prevalence of vein infusion phlebitis after PPI intravenous infusion in aging people
The secondary of objective of the study if to determinate the factors of risk of vein infusion phlebitis
The primary of objective of the study is to determinate the prevalence of vein infusion phlebitis after PPI intravenous infusion in aging people
The secondary of objective of the study if to determinate the factors of risk of vein infusion phlebitis
Detailed Description:
This is a multicenter observational study 5 centers will participate to the study Aging patients undergoing PPI intravenous infusion therapy will be proposed to be enrolled in the study Paramedical observation will be performed during 5 days for each enrolled patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2020-A02319-30 | REGISTRY | IDRCB | None |